# Texoma Regional Blood Center – FDA Inspection, Aug 23, 2024

Source: https://www.keypedia.com/records/fda_inspections/texoma-regional-blood-center/67939568-8927-40a1-abb1-47775ff2ed8d
Source feed: FDA_Inspections

> FDA inspection 1247483 of Texoma Regional Blood Center, August 23, 2024. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR parts 606 and 630. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1247483
- Company Name: Texoma Regional Blood Center
- Inspection Date: 2024-08-23
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 4

## Related Documents

- [FDA Inspection 1088682 - 2019-05-03](https://www.keypedia.com/records/fda_inspections/texoma-regional-blood-center/301595a4-8412-4c57-a970-b7ed6ff6e142)
- FDA Inspection 1003237 - 2017-01-30
- FDA Inspection 915249 - 2015-02-20
- FDA Inspection 810912 - 2012-12-13
- FDA Inspection 700321 - 2010-12-09

## Related Officers

- [Emily S. McGann](https://www.keypedia.com/people/emily-s-mcgann/43891ff3-bd70-4337-b61c-e16cc7ad0468)

Company: https://www.keypedia.com/companies/texoma-regional-blood-center/cc65fa03-5945-4ee8-b9fb-5fb690840c98

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
